Frontier Medicines' FMC-376 shrank tumors in 56% of 18 evaluable patients with KRAS G12C lung cancer, including those resistant to existing KRAS inhibitors.

Market momentum is deeply negative, but Q4 rallies may favor value, dividends, and select cyclicals. Click for a look at the ...

Ukraine's drone pilots can only fly them so far before signal is lost. But other drones act as hovering signal relays to ...